Abstract:Background The chemokine receptor 7 (CCR7) mediates survival and invasiveness of metastatic squamous cell carcinoma of the head and neck (SCCHN) to regional lymph nodes. Constitutive prosurvival signaling by the phosphoinositide-3 kinase/Akt pathway has been observed in SCCHN cells independent of epidermal growth factor receptor (EGFR) signaling. Methods Human SCCHN cell lines were treated with agents that block or activate CCR7-mediated signaling, and Akt activation, cell viability in the presence or absence of EGFR inhibition, and cisplatin-induced apoptosis (in the presence or absence of Akt inhibition) were assessed by immunoblotting, the MTT assay, and the detection of annexin V, respectively. Expression and secretion of chemokines by primary tumors, metastatic nodes, and benign nodes of patients with SCCHN were determined by quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The role of paracrine activation of CCR7 on tumor growth was analyzed by comparing the growth of orthotopic tumors derived from B7E3 murine oral carcinoma cells in wild-type BALB/c mice, in paucity of lymphoid T cell (plt, deficient in CCL19 and CCL21 expression) mice, and in plt mice in which the implanted B7E3 cells overexpressed CCR7 (n = 14 mice per group). Results In the absence of exogenous ligand treatment, blockade of CCR7 signaling reduced levels of phosphorylated (activated) Akt and decreased SCCHN cell viability by up to 59% (95% confidence interval [CI] = 58.2% to 59.8%), enhancing the effect of EGFR inhibition. CCR7 stimulation protected metastatic SCCHN cells from cisplatin-induced apoptosis in an Akt-dependent manner. Metastatic nodes expressed and secreted higher levels of CCL19 than benign nodes or primary tumors. CCR7-positive murine SCCHN tumors grew more slowly in plt mice than in control BALB/c mice (mean average tumor volume on day 20 = 12.2 and 26.5 mm(3), respectively; difference = 14.3 mm(3), 95% CI = 12.3 to 17.1 mm(3)). Conclusions Secretion of CCL19 and CCL21 by SCCHN cells and by paracrine sources combine to promote activation of CCR7 prosurvival signaling associated with tumor progression and disease relapse. CCR7 and its cognate chemokines may be useful biomarkers of SCCHN progression, and blockade of CCR7-mediated signaling may enhance the efficacy of platinum- and EGFR-based therapies.

Inhibition of CCR7 Promotes NF-κB-dependent Apoptosis and Suppresses Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

CCL21/CCR7 Prevents Apoptosis Via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells.

Silencing Of Cxcr7 Gene Represses Growth And Invasion And Induces Apoptosis In Colorectal Cancer Through Erk And Beta-Arrestin Pathways

Ccr7 Mediates Human Breast Cancer Cell Invasion, Migration by Inducing Epithelial-Mesenchymal Transition and Suppressing Apoptosis Through Akt Pathway

CCR9–CCL25 Interaction Suppresses Apoptosis of Lung Cancer Cells by Activating the PI3K/Akt Pathway

CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck

Lymphatic Metastasis of NSCLC Involves Chemotaxis Effects of Lymphatic Endothelial Cells Through the CCR7–CCL21 Axis Modulated by TNF-α

Cirs-7 Targeting Mir-7 Modulates The Progression Of Non-Small Cell Lung Cancer In A Manner Dependent On Nf-Kappa B Signalling

CCR7 Promote Lymph Node Metastasis Via Regulating VEGF-C/D-R3 Pathway in Lung Adenocarcinoma

Ccl21/Ccr7 Promotes G(2)/M Phase Progression Via the Erk Pathway in Human Non-Small Cell Lung Cancer Cells

Expression and Regulation Effects of Chemokine Receptor 7 in Colon Cancer Cells

Ccr1 Knockdown Suppresses Human Non-Small Cell Lung Cancer Cell Invasion

Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells

Upregulation of the Chemokine Receptor CCR7 Expression by HIF-1αand HIF-2α in Non-Small Cell Lung Cancer

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.

Effect of AXL on the Epithelial-to-mesenchymal Transition in Non-Small Cell Lung Cancer

A Critical Role of CCR7 in Invasiveness and Metastasis of SW620 Colon Cancer Cell in Vitro and in Vivo

[CCR7 Silence by Sirna Inhibits Proliferation, Invasion and Promotes Apoptosis of Human MG63 Osteosarcoma Cells].

MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway

CCR7 affects the tumor microenvironment by regulating the activation of naïve CD8+ T cells to promote the proliferation of oral squamous cell carcinoma

Regulation the CCR7 Expression in Tumor Cells by COX-2